Savara Inc SVRA

$4.83 -0.05 (-1.02%)

Valuation

Market cap
955,389,000
Revenue TTM
$0
Net income TTM
$-118,840,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.21

Trading

Volume
2,514,120
Avg volume
1,797,270
Day's range
$4.64 – $4.88
Shares out
205,460,000
Stochastic %K
44%
Beta
0.20
Analysts
Strong Sell
Price target
$10.94

Price

Company profile

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.

Industry
Biotechnology
Sector
Healthcare
Phone
(512) 614-1848
Website
https://www.savarapharma.com
Address
The Tannery Building, Suite 200 19 West College Avenue, Yardley, United States

Latest news

Stocktwits

Richterscale Oct 8, 6:24 PM
$SVRA I’ll take $25 a share please
0 replies
Cap_00 Oct 8, 6:01 PM
$SVRA 1.5-3B/yr opportunity from US, EU, Japan. Approval is a foregone conclusion. Even 1B year from these 3 areas is enough for 3B valuation. US approval Nov, EU 1h 2027. Stupid cheap.
0 replies
art62 Oct 7, 1:48 PM
$SVRA the response to the JP Morgan 12 dollar PT to me indicates that the some people need a little reassurance. and the past recent behaviour is nothing but nervousness
0 replies
notreload_ai Oct 7, 1:06 PM
JPMorgan started $SVRA at Overweight and $12, pointing to a Nov. 22 FDA decision, later U.K. and EU reviews, and blockbuster potential. https://notreload.xyz/xy/jpmorgan-rates-savara-overweight-before-nov-22/
0 replies
Quantumup Oct 7, 10:17 AM
Citizens reiterated $SVRA Market Outperform-$10 ~Assigns 90% PoS for a Molbreevi Approval—Sees Shares as Undervalued—its DCF Analysis Shows an NPV of $2.6B $RHHBY $BIIB Here's what Citizens said in its note: https://x.com/Quantumup1/status/2107777065214722369?s=20
0 replies
Spacemonkey1 Oct 6, 2:41 PM
$SVRA just junk at low volume to induce retail panic selling so people can clean up shares at low prices, hold the fort, there’s no reason the price is dropping outside of that manipulation
0 replies
Richterscale Oct 6, 2:35 PM
$SVRA News? I can’t find anything
0 replies
joe9 Oct 6, 2:27 PM
$SVRA If they screw this up again...
2 replies